Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 146
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT06688435 A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR … |
SYS6020 injection | Myasthénie | Phase 1 | RECRUITING | En attente / non publié | CSPC ZhongQi Pharmaceutical Techn… | China · Qilu Hospital, Shandong University, Jinan, Ch… | 2025-03-04 → 2033-05-01 | Ouvrir |
| NCT07247279 Epidemiological Study of Treatment Approaches in AChR-Antibody Positive… |
Epidemiological Study of Treatmen… | Myasthénie | À vérifier | RECRUITING | En attente / non publié | AstraZeneca | Russia · Research Site, Kazan', Russia | Research Sit… | 2025-12-23 → 2029-12-31 | Ouvrir |
| NCT06517758 A Phase III Study to Investigate Efficacy, Safety and Tolerability of I… |
Iptacopan | Myasthénie | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Australia, Brazil, China, D… | 2024-07-31 → 2032-05-27 | Ouvrir |
| NCT07284420 ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on… |
Efgartigimod IV | Myasthénie | Phase 2 | RECRUITING | En attente / non publié | argenx | United States, Belgium, Germany, Greece, Italy, Japan… | 2025-12-19 → 2028-03-07 | Ouvrir |
| NCT06463587 Efficacy and Safety of a New Formulation of Oral Cladribine Compared Wi… |
Cladribine Low Dose | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | Merck Healthcare KGaA, Darmstadt,… | United States, Argentina, Australia, Belgium, Bulgari… | 2024-06-25 → 2030-11-12 | Ouvrir |
| NCT04225871 RAISE-XT — Open-Label Extension of Zilucoplan in Subjects With Generali… |
zilucoplan (RA101495) | Myasthénie | Phase 3 | COMPLETED | En attente / non publié | UCB Biopharma SRL | United States, Canada, France, Germany, Italy, Japan,… | 2019-12-23 → 2026-07-31 | Ouvrir |
| NCT07556120 Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia G… |
HN2301 injection | Myasthénie | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Shenzhen MagicRNA Biotechnology C… | China · The First Affiliated Hospital of University o… | 2026-12-31 → 2028-12-31 | Ouvrir |
| NCT07761026 AXIS MG Patient Registry |
AXIS MG Patient Registry | Myasthénie | À vérifier | RECRUITING | En attente / non publié | Autoimmune Neurology Alliance | United States · Alira Health - Virtual/Remote Site - … | 2026-03-19 → 2036-03 | Ouvrir |
| NCT06881173 The Effectiveness of Bu Zhong Yi Qi Tang in Patients with Myasthenia Gr… |
Bu Zhong Yi Qi Tang | Myasthénie | NA | RECRUITING | En attente / non publié | Cheng, yu-ting | Taiwan · Shin Kong Wu Ho-Su Memorial Hospital, Taipei… | 2022-06-14 → 2025-06-13 | Ouvrir |
| NCT07033559 Detecting Fatigue From Voice in Generalised Myasthenia Gravis |
Detecting Fatigue From Voice in G… | Myasthénie | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Thymia Limited | Non communiqué | 2026-02 → 2026-12 | Ouvrir |
| NCT06617741 MGFAPR — Myasthenia Gravis Foundation of America Global MG Patient Regi… |
MGFAPR — Myasthenia Gravis Founda… | Myasthénie | À vérifier | RECRUITING | En attente / non publié | Myasthenia Gravis Foundation of A… | United States · Myasthenia Gravis Foundation of Ameri… | 2013-10-12 → 2029-09-19 | Ouvrir |
| NCT03905473 Physical Activity and Fatigue in Myasthenia Gravis |
Physical Activity and Fatigue in … | Myasthénie | À vérifier | COMPLETED | En attente / non publié | Rigshospitalet, Denmark | Denmark · Rigshospitalet, Copenhagen, Denmark | 2019-06-01 → 2020-10-10 | Ouvrir |
| NCT04176211 The Impact of Myasthenia Gravis in the Real World |
The Impact of Myasthenia Gravis i… | Myasthénie | À vérifier | COMPLETED | En attente / non publié | Vitaccess Ltd | United Kingdom · Vitaccess Ltd, Oxford, United Kingdom | 2019-12-12 → 2024-05-31 | Ouvrir |
| NCT01480596 The Evaluation of Belimumab in Myasthenia Gravis (MG) |
Belimumab | Myasthénie | Phase 2 | COMPLETED | En attente / non publié | Johns Hopkins University | United States, Canada, Germany, Italy · GSK Investiga… | 2013-04 → 2015-10 | Ouvrir |
| NCT07022028 GUIMAUVE — Ventilator Weaning Practices in Patients Intubated for Guill… |
GUIMAUVE — Ventilator Weaning Pra… | Myasthénie | À vérifier | COMPLETED | En attente / non publié | Poitiers University Hospital | France · CHU de POITIERS, Poitiers, France | 2024-02-27 → 2024-11-06 | Ouvrir |
| NCT07221838 OCTAGON — A Study to Investigate OCS Tapering in Adult Participants Wit… |
Oral Corticosteroid Tapering Sche… | Myasthénie | Phase 4 | RECRUITING | En attente / non publié | Alexion Pharmaceuticals, Inc. | United States, Germany, Italy, Japan · Research Site,… | 2026-03-04 → 2027-08-27 | Ouvrir |
| NCT03770403 ADAPT+ — A Safety and Tolerability Study of ARGX-113 in Patients With M… |
ARGX-113 | Myasthénie | Phase 3 | COMPLETED | En attente / non publié | argenx | United States, Belgium, Canada, Czechia, Denmark, Fra… | 2019-03-01 → 2022-06-30 | Ouvrir |
| NCT06471361 A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-inj… |
Zilucoplan | Myasthénie | Phase 3 | COMPLETED | En attente / non publié | UCB Biopharma SRL | United States, Poland, United Kingdom · Dv0013 40605,… | 2024-08-27 → 2025-02-03 | Ouvrir |
| NCT03896295 An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability… |
M281 | Myasthénie | Phase 2 | TERMINATED | En attente / non publié | Momenta Pharmaceuticals, Inc. | United States, Belgium, Canada, Germany, Italy, Polan… | 2019-08-06 → 2020-12-09 | Ouvrir |
| NCT05919407 IMPACT-MG — Pyridostigmine and Amifampridine for Myasthenia Gravis |
Pyridostigmine | Myasthénie | Phase 3 | UNKNOWN | En attente / non publié | Leiden University Medical Center | Netherlands · Leiden University Medical Center, Leide… | 2023-03-22 → 2024-09-22 | Ouvrir |
| NCT01793168 CoRDS — Rare Disease Patient Registry & Natural History Study - Coordin… |
CoRDS — Rare Disease Patient Regi… | Myasthénie | À vérifier | RECRUITING | En attente / non publié | Sanford Health | United States, Australia · Online Patient Enrollment … | 2010-07 → 2100-12 | Ouvrir |
| NCT06836973 Blinatumomab for Treatment of Refractory Myasthenia Gravis |
Blinatumomab | Myasthénie | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | Non communiqué | 2025-04-01 → 2028-06-30 | Ouvrir |
| NCT02317224 The Safety and Efficacy of "3-Hole" Subxiphorid Approach in the Treatme… |
"3-Hole" subxiphorid and subcosta… | Myasthénie | Phase 2 | UNKNOWN | En attente / non publié | Tang-Du Hospital | China · Tangdu hospital, Xi'an, China | 2014-08 → 2024-12 | Ouvrir |
| NCT04541875 Medication Adherence and Non-adherence in Adults With Rare Disease |
Medication Adherence and Non-adhe… | Myasthénie | À vérifier | WITHDRAWN | En attente / non publié | Xperiome | Non communiqué | 2021-01 → 2022-09 | Ouvrir |
| NCT04302103 A Study of TACI（Transmembrane Activator and Calcium-modulator and Cyclo… |
RC18 160mg | Myasthénie | Phase 2 | COMPLETED | En attente / non publié | RemeGen Co., Ltd. | China · Affiliated Hospital of North Sichuan Medical … | 2020-07-07 → 2022-02-11 | Ouvrir |